Potential of a glucagon-like peptide-1 receptor/glucose-dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity and type 2 diabetes

被引:1
作者
Araki, Eiichi [1 ,2 ]
Sakaguchi, Masaji [1 ]
Fukuda, Kazuki [1 ,2 ]
Kondo, Tatsuya [1 ]
机构
[1] Kumamoto Univ, Fac Life Sci, Dept Metab Med, Kumamoto, Japan
[2] Kumamoto Univ, Fac Life Sci, Ctr Metab Regulat Hlth Aging, Kumamoto, Japan
关键词
DUAL GIP; GLP-1; AGONIST; WEIGHT;
D O I
10.1111/jdi.13896
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 9 条
[1]   Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist [J].
Bossart, Martin ;
Wagner, Michael ;
Elvert, Ralf ;
Evers, Andreas ;
Hubschle, Thomas ;
Kloeckener, Tim ;
Lorenz, Katrin ;
Moessinger, Christine ;
Eriksson, Olof ;
Velikyan, Irina ;
Pierrou, Stefan ;
Johansson, Lars ;
Dietert, Gabriele ;
Dietz-Baum, Yasmin ;
Kissner, Thomas ;
Nowotny, Irene ;
Einig, Christine ;
Jan, Christelle ;
Rharbaoui, Faiza ;
Gassenhuber, Johann ;
Prochnow, Hans-Peter ;
Agueusop, Inoncent ;
Porksen, Niels ;
Smith, William B. ;
Nitsche, Almut ;
Konkar, Anish .
CELL METABOLISM, 2022, 34 (01) :59-+
[2]   Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia [J].
Christensen, Mikkel B. ;
Lund, Asger ;
Calanna, Salvatore ;
Jorgensen, Niklas R. ;
Holst, Jens J. ;
Vilsboll, Tina ;
Knop, Filip K. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (01) :288-294
[3]   LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept [J].
Coskun, Tamer ;
Sloop, Kyle W. ;
Loghin, Corina ;
Alsina-Fernandez, Jorge ;
Urva, Shweta ;
Bokvist, Krister B. ;
Cui, Xuewei ;
Briere, Daniel A. ;
Cabrera, Over ;
Roell, William C. ;
Kuchibhotla, Uma ;
Moyers, Julie S. ;
Benson, Charles T. ;
Gimeno, Ruth E. ;
D'Alessio, David A. ;
Haupt, Axel .
MOLECULAR METABOLISM, 2018, 18 :3-14
[4]   Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 [J].
Drucker, Daniel J. .
CELL METABOLISM, 2018, 27 (04) :740-756
[5]   Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates [J].
Elvert, Ralf ;
Herling, Andreas W. ;
Bossart, Martin ;
Weiss, Tilo ;
Zhang, Baohong ;
Wenski, Pierre ;
Wandschneider, Joern ;
Kleutsch, Sabrina ;
Butty, Uwe ;
Kannt, Aimo ;
Wagner, Michael ;
Haack, Torsten ;
Evers, Andreas ;
Dudda, Angela ;
Lorenz, Martin ;
Keil, Stefanie ;
Larsen, Philip J. .
DIABETES OBESITY & METABOLISM, 2018, 20 (08) :1836-1851
[6]   Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys [J].
Elvert, Ralf ;
Bossart, Martin ;
Herling, Andreas W. ;
Weiss, Tilo ;
Zhang, Baohong ;
Kannt, Aimo ;
Wagner, Michael ;
Haack, Torsten ;
Evers, Andreas ;
Dudda, Angela ;
Keil, Stefanie ;
Lorenz, Martin ;
Lorenz, Katrin ;
Riz, Michela ;
Hennerici, Wolfgang ;
Larsen, Philip J. .
ENDOCRINOLOGY, 2018, 159 (08) :3105-3119
[7]   A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents [J].
Finan, Brian ;
Yang, Bin ;
Ottaway, Nickki ;
Smiley, David L. ;
Ma, Tao ;
Clemmensen, Christoffer ;
Chabenne, Joe ;
Zhang, Lianshan ;
Habegger, Kirk M. ;
Fischer, Katrin ;
Campbell, Jonathan E. ;
Sandoval, Dar Leen ;
Seeley, Randy J. ;
Bleicher, Konrad ;
Uhles, Sabine ;
Riboulet, William ;
Funk, Jurgen ;
Hertel, Cornelia ;
Belli, Sara ;
Sebokova, Elena ;
Conde-Knape, Karin ;
Konkar, Anish ;
Drucker, Daniel J. ;
Gelfanov, Vasily ;
Pfluger, Paul T. ;
Muller, Timo D. ;
Perez-Tilve, Diego ;
DiMarchi, Richard D. ;
Tschop, Matthias H. .
NATURE MEDICINE, 2015, 21 (01) :27-36
[8]   Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes [J].
Frias, Juan P. ;
Davies, Melanie J. ;
Rosenstock, Julio ;
Manghi, Federico C. Perez ;
Lando, Laura Fernandez ;
Bergman, Brandon K. ;
Liu, Bing ;
Cui, Xuewei ;
Brown, Katelyn .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06) :503-515
[9]   Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial [J].
Rosenstock, Julio ;
Wysham, Carol ;
Frias, Juan P. ;
Kaneko, Shizuka ;
Lee, Clare J. ;
Lando, Laura Fernandez ;
Mao, Huzhang ;
Cui, Xuewei ;
Karanikas, Chrisanthi A. ;
Thieu, Vivian T. .
LANCET, 2021, 398 (10295) :143-155